Sarcopenia: European consensus on definition and diagnosis
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 80 of the 80 references it cites were found in a registry or an index.
Abstract
The European Working Group on Sarcopenia in Older People (EWGSOP) developed a practical clinical definition and consensus diagnostic criteria for age-related sarcopenia. EWGSOP included representatives from four participant organisations, i.e. the European Geriatric Medicine Society, the European Society for Clinical Nutrition and Metabolism, the International Association of Gerontology and Geriatrics—European Region and the International Association of Nutrition and Aging. These organisations endorsed the findings in the final document. The group met and addressed the following questions, using the medical literature to build evidence-based answers: (i) What is sarcopenia? (ii) What parameters define sarcopenia? (iii) What variables reflect these parameters, and what measurement tools and cut-off points can be used? (iv) How does sarcopenia relate to cachexia, frailty and sarcopenic obesity? For the diagnosis of sarcopenia, EWGSOP recommends using the presence of both low muscle mass + low muscle function (strength or performance). EWGSOP variously applies these characteristics to further define conceptual stages as ‘presarcopenia’, ‘sarcopenia’ and ‘severe sarcopenia’. EWGSOP reviewed a wide range of tools that can be used to measure the specific variables of muscle mass, muscle strength and physical performance. Our paper summarises currently available data defining sarcopenia cut-off points by age and gender; suggests an algorithm for sarcopenia case finding in older individuals based on measurements of gait speed, grip strength and muscle mass; and presents a list of suggested primary and secondary outcome domains for research. Once an operational definition of sarcopenia is adopted and included in the mainstream of comprehensive geriatric assessment, the next steps are to define the natural course of sarcopenia and to develop and define effective treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The European Working Group for the Study of Sarcopenia (EWGSOP)156 identified sarcopenia cut-off points and tools for its measurement. They recognized the lack of diagnostic criteria for sarcopenia but integrated low muscle mass and function (strength or performance) in their terminology, believing that the relationship between these two measures is not linear nor bidirectional73,156,181.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [156]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This algorithm was meant for clinical application using gait speed (<0.8 m/s) before muscle mass or strength measurement.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [156]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Also, the cut-off points for the Asian populations [9] are lower than for the non-Asian individuals [7] in both genders, with young people of the same ethnic group as reference.”
From Prevalence of sarcopenia in the world: a systematic review and meta- analysis of general population studies (2017) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition to the amount of skeletal muscle, other conditions also affect functional outcomes: muscle quality, total body fat, neurologic function, cardiovascular and pulmonary function, and other comorbid conditions.16,208”
From Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group (2013) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In older people, loss of muscle strength is associated with reduced functional capacity and increased health care costs.16”
From Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group (2013) · cites this paper as [16]
Experimental — accuracy not yet measured
11 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Frailty in Older Adults: Evidence for a Phenotype
Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W. J., Burke, G., et al. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.3.m146 · Cited by 24,907 · cited 3×
“Men: Based on quartiles of study group (n = 5,317) [27]”
BackgroundGuralnik, J. M., Simonsick, E. M., Ferrucci, L., Glynn, R. J., Berkman, L. F., Blazer, D. G., Scherr, P. A., & Wallace, R. B. (1994) · Journal of Gerontology · doi:10.1093/geronj/49.2.m85 · Cited by 9,792 · cited 1×
“The SPPB evaluates balance, gait, strength and endurance by examining an individual’s ability to stand with the feet together in side-by-side, semi-tandem and tandem positions, time to walk 8 ft and time to rise from a chair and return to the seated position five times [58].”
BackgroundEpidemiology of Sarcopenia among the Elderly in New Mexico
Baumgartner, R. N., Koehler, K. M., Gallagher, D., Romero, L., Heymsfield, S. B., Ross, R. R., Garry, P. J., & Lindeman, R. D. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009520 · Cited by 4,004 · cited 13×
“The re- searchers concluded that BIA was a clinically relevant measure muscle function, which would be particularly useful for patients unable or unwilling to perform grip strength tests.”
BackgroundMethodInfluentialPrado, C. M., Lieffers, J. R., McCargar, L. J., Reiman, T., Sawyer, M. B., Martin, L., & Baracos, V. E. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70153-0 · Cited by 3,238 · cited 1×
“In conditions such as malignancy, rheumatoid arthritis and ageing, lean bodymass is lost while fat mass may be preserved or even increased [28].”
BackgroundJanssen, I., Heymsfield, S. B., & Ross, R. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50216.x · Cited by 3,139 · cited 2×
“[67] also used standard deviations to define sarcopenia, measured in terms of skeletal muscle index (SMI), where SMI = (skeletal muscle mass/ body mass) × 100.”
BackgroundMethodGoodpaster, B. H., Park, S. W., Harris, T. B., Kritchevsky, S. B., Nevitt, M., Schwartz, A. V., Simonsick, E. M., Tylavsky, F. A., Visser, M., Newman, A. B., et al. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.10.1059 · Cited by 3,083 · cited 3×
“Intramuscular and visceral fat increase with ageing while subcutaneous fat declines [18, 32, 33].”
BackgroundGuralnik, J. M., Ferrucci, L., Pieper, C. F., Leveille, S. G., Markides, K. S., Ostir, G. V., Studenski, S., Berkman, L. F., & Wallace, R. B. (2000) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/55.4.m221 · Cited by 2,898 · cited 2×
“suggested that timed usual gait provides a predictive value for the onset of disability [62].”
BackgroundMeaningful change and responsiveness in common physical performance measures in older adults.
Perera, S., Mody, S. H., Woodman, R. C., & Studenski, S. A. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00701.x · Cited by 2,513 · cited 1×
“Meaningful changes in the SPPB have been defined [59, 60].”
BackgroundEvans, W. J., Morley, J. E., Argilés, J., Bales, C., Baracos, V., Guttridge, D., Jatoi, A., Kalantar-Zadeh, K., Lochs, H., Mantovani, G., et al. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2008.06.013 · Cited by 2,450 · cited 2×
“Sarcopenia is one of the elements of the proposed definition for cachexia [22].”
BackgroundSarcopenia: origins and clinical relevance
Rosenberg, I. H. (1997) · The Journal of Nutrition · doi:10.1093/jn/127.5.990s · Cited by 2,399 · cited 1×
“In 1989, Irwin Rosenberg proposed the term ‘sarcopenia’ (Greek ‘sarx’ or flesh + ‘penia’ or loss) to describe this age-related decrease of muscle mass [1, 2].”
Background
Research works printed but not linked: 1
- Abellan van Kan, 2009, Gait speed as a marker of adverse outcomes, 881
Cited by
Items 301–400 of 1,247
ESPEN guideline on clinical nutrition in hospitalized patients with acute or chronic kidney disease
Fiaccadori, E., Sabatino, A., Barazzoni, R., Carrero, J. J., Cupisti, A., De Waele, E., Jonckheer, J., Singer, P., & Cuerda, C. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.01.028 · Cited by 277
Frailty, Sarcopenia and Diabetes
Morley, J. E., Malmstrom, T. K., Rodriguez-Mañas, L., & Sinclair, A. J. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.10.001 · Cited by 277
Evaluation of accelerometer based multi-sensor versus single-sensor activity recognition systems
Gao, L., Bourke, A. K., & Nelson, J. (2014) · Medical Engineering & Physics · doi:10.1016/j.medengphy.2014.02.012 · Cited by 266
SARC-F for Screening of Sarcopenia Among Older Adults: A Meta-analysis of Screening Test Accuracy
Ida, S., Kaneko, R., & Murata, K. (2018) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2018.04.001 · Cited by 265
Frailty and sarcopenia - newly emerging and high impact complications of diabetes
Sinclair, A. J., Abdelhafiz, A. H., & Rodríguez-Mañas, L. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.05.003 · Cited by 276
Diagnostic accuracy of body mass index to identify obesity in older adults: NHANES 1999–2004
Batsis, J. A., Mackenzie, T. A., Bartels, S. J., Sahakyan, K. R., Somers, V. K., & Lopez-Jimenez, F. (2016) · International Journal of Obesity · doi:10.1038/ijo.2015.243 · Cited by 275
The health economics burden of sarcopenia: a systematic review
Bruyère, O., Beaudart, C., Ethgen, O., Reginster, J.-Y., & Locquet, M. (2019) · Maturitas · doi:10.1016/j.maturitas.2018.11.003 · Cited by 275
Gomez‐Perez, S. L., Haus, J. M., Sheean, P., Patel, B., Mar, W., Chaudhry, V., McKeever, L., & Braunschweig, C. (2016) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607115604149 · Cited by 275
Muscle and bone mass in middle-aged women: role of menopausal status and physical activity
Sipilä, S., Törmäkangas, T., Sillanpää, E., Aukee, P., Kujala, U. M., Kovanen, V., & Laakkonen, E. K. (2020) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12547 · Cited by 228
“51 Sedentary 21 (9) 24 (13) 16 (8) 35 (12) Low 68 (29) 50 (28) 54 (28) 78 (27) Moderate 90 (39) 70 (39) 90 (47) 118 (41) High 55 (24) 35 (20) 32 (17) 57 (20)”
Tian, S., & Xu, Y. (2016) · Geriatrics & Gerontology International · doi:10.1111/ggi.12579 · Cited by 274
Live strong and prosper: the importance of skeletal muscle strength for healthy ageing
McLeod, M., Breen, L., Hamilton, D. L., & Philp, A. (2016) · Biogerontology · doi:10.1007/s10522-015-9631-7 · Cited by 274
Defining Sarcopenia in Terms of Incident Adverse Outcomes
Woo, J., Leung, J., & Morley, J. E. (2015) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.11.013 · Cited by 261
The role of E3 ubiquitin-ligases MuRF-1 and MAFbx in loss of skeletal muscle mass
Rom, O., & Reznick, A. Z. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.12.031 · Cited by 256
Izquierdo, M., de Souto Barreto, P., Arai, H., Bischoff-Ferrari, H. A., Cadore, E. L., Cesari, M., Chen, L.-K., Coen, P. M., Courneya, K. S., Duque, G., et al. (2025) · The Journal of nutrition, health and aging · doi:10.1016/j.jnha.2024.100401 · Cited by 273
Self-citationBarbosa-Silva, T. G., Bielemann, R. M., Gonzalez, M. C., & Menezes, A. M. B. (2016) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12049 · Cited by 250
Okumura, S., Kaido, T., Hamaguchi, Y., Fujimoto, Y., Masui, T., Mizumoto, M., Hammad, A., Mori, A., Takaori, K., & Uemoto, S. (2015) · Surgery · doi:10.1016/j.surg.2015.02.002 · Cited by 271
Yang, M., Hu, X., Wang, H., Zhang, L., Hao, Q., & Dong, B. (2017) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12163 · Cited by 263
Gielen, E., Beckwée, D., Delaere, A., De Breucker, S., Vandewoude, M., Bautmans, I., the Sarcopenia Guidelines Development Group of the Belgian Society of Gerontology and Geriatrics (BSGG), Bautmans, I., Beaudart, C., Beckwée, D., et al. (2021) · Nutrition Reviews · doi:10.1093/nutrit/nuaa011 · Cited by 269
Self-citationZdzieblik, D., Oesser, S., Baumstark, M. W., Gollhofer, A., & König, D. (2015) · British Journal of Nutrition · doi:10.1017/s0007114515002810 · Cited by 269
Mortality as an adverse outcome of sarcopenia
Arango-Lopera, V. E., Arroyo, P., Gutiérrez-Robledo, L. M., Perez-Zepeda, M. U., & Cesari, M. (2013) · The Journal of nutrition, health and aging · doi:10.1007/s12603-012-0434-0 · Cited by 262
Verlaan, S., Aspray, T. J., Bauer, J. M., Cederholm, T., Hemsworth, J., Hill, T. R., McPhee, J. S., Piasecki, M., Seal, C., Sieber, C. C., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2015.11.013 · Cited by 268
“Relatively little information is available comparing nutrient intake and serum nutrient concentrations between sarcopenic and healthy older adults [1].”
BackgroundSelf-citationCachexia in patients with oesophageal cancer
Anandavadivelan, P., & Lagergren, P. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.200 · Cited by 262
Yamamoto, K., Nagatsuma, Y., Fukuda, Y., Hirao, M., Nishikawa, K., Miyamoto, A., Ikeda, M., Nakamori, S., Sekimoto, M., Fujitani, K., et al. (2017) · Gastric Cancer · doi:10.1007/s10120-016-0683-4 · Cited by 257
Tools in the Assessment of Sarcopenia
Cooper, C., Fielding, R., Visser, M., van Loon, L. J., Rolland, Y., Orwoll, E., Reid, K., Boonen, S., Dere, W., Epstein, S., et al. (2013) · Calcified Tissue International · doi:10.1007/s00223-013-9757-z · Cited by 246
“European Working Group on Sarcopenia in Older People [10] ‘‘Sarcopenia is a syndrome characterized by progressive and generalized loss of skeletal muscle mass and strength with a risk of adverse outcomes such as physical disability, poor quality of life and death.”
Self-citationSarcopenia and Inflammatory Bowel Disease: A Systematic Review
Ryan, E., McNicholas, D., Creavin, B., Kelly, M. E., Walsh, T., & Beddy, D. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy212 · Cited by 248
Bhanji, R. A., Narayanan, P., Allen, A. M., Malhi, H., & Watt, K. D. (2017) · Hepatology · doi:10.1002/hep.29420 · Cited by 258
Performance of SARC-F in Regard to Sarcopenia Definitions, Muscle Mass and Functional Measures
Bahat, G., Yilmaz, O., Kiliç, C., Oren, M. M., & Karan, M. A. (2018) · The Journal of nutrition, health and aging · doi:10.1007/s12603-018-1067-8 · Cited by 263
“Four different current sarcopenia definitions [European Working Group on Sarcopenia in Older People’s (EWGSOP); Foundation for the National Institutes of Health (FNIH), International Working Group on Sarcopenia (IWGS) and Society on Sarcopenia, Cachexia and Wasting Disorders (SCWD)] were included (17-20).”
Cummings, S. R., Studenski, S., & Ferrucci, L. (2014) · JAMA · doi:10.1001/jama.2014.3033 · Cited by 250
Role of exercise in age-related sarcopenia
Yoo, S.-Z., No, M.-H., Heo, J.-W., Park, D.-H., Kang, J.-H., Kim, S. H., & Kwak, H.-B. (2018) · Journal of Exercise Rehabilitation · doi:10.12965/jer.1836268.134 · Cited by 245
“Indeed, the European Working Group on Sarcopenia in Older People proposed that low muscle mass and low muscle function (strength or performance) both be considered essential diagnostic features of sarcopenia (Cruz-Jentoft et al., 2010).”
BackgroundVikberg, S., Sörlén, N., Brandén, L., Johansson, J., Nordström, A., Hult, A., & Nordström, P. (2019) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2018.09.011 · Cited by 261
Sarcopenic obesity: time to meet the challenge
Barazzoni, R., Bischoff, S. C., Boirie, Y., Busetto, L., Cederholm, T., Dicker, D., Toplak, H., Van Gossum, A., Yumuk, V., & Vettor, R. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2018.04.018 · Cited by 260
Self-citationPapadopoulou, S. K., Papadimitriou, K., Voulgaridou, G., Georgaki, E., Tsotidou, E., Zantidou, O., & Papandreou, D. (2021) · Nutrients · doi:10.3390/nu13124499 · Cited by 231
“Furthermore, it is predicted that it will affect more than 500 million elderly people by 2050 [13].”
BackgroundQuality of life and physical components linked to sarcopenia: The SarcoPhAge study
Beaudart, C., Reginster, J. Y., Petermans, J., Gillain, S., Quabron, A., Locquet, M., Slomian, J., Buckinx, F., & Bruyère, O. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.05.003 · Cited by 248
Decreased Tongue Pressure is Associated with Sarcopenia and Sarcopenic Dysphagia in the Elderly
Maeda, K., & Akagi, J. (2015) · Dysphagia · doi:10.1007/s00455-014-9577-y · Cited by 252
Sarcopenia is an independent risk factor of dysphagia in hospitalized older people
Maeda, K., & Akagi, J. (2016) · Geriatrics & Gerontology International · doi:10.1111/ggi.12486 · Cited by 251
Prognostic Value of Sarcopenia in Lung Cancer
Yang, M., Shen, Y., Tan, L., & Li, W. (2019) · Chest · doi:10.1016/j.chest.2019.04.115 · Cited by 258
Sarcopenia in the Older Adult With Cancer
Williams, G. R., Dunne, R. F., Giri, S., Shachar, S. S., & Caan, B. J. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.21.00102 · Cited by 248
Muscle dysfunction in cancer patients
Christensen, J. F., Jones, L. W., Andersen, J. L., Daugaard, G., Rorth, M., & Hojman, P. (2014) · Annals of Oncology · doi:10.1093/annonc/mdt551 · Cited by 242
Osteosarcopenic obesity: the role of bone, muscle, and fat on health
Ormsbee, M. J., Prado, C. M., Ilich, J. Z., Purcell, S., Siervo, M., Folsom, A., & Panton, L. (2014) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-014-0146-x · Cited by 257
A North American Expert Opinion Statement on Sarcopenia in Liver Transplantation
Carey, E. J., Lai, J. C., Sonnenday, C., Tapper, E. B., Tandon, P., Duarte‐Rojo, A., Dunn, M. A., Tsien, C., Kallwitz, E. R., Ng, V., et al. (2019) · Hepatology · doi:10.1002/hep.30828 · Cited by 246
“9) Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia.”
InfluentialNutrition and Sarcopenia: A Review of the Evidence and Implications for Preventive Strategies
Robinson, S., Cooper, C., & Aihie Sayer, A. (2012) · Journal of Aging Research · doi:10.1155/2012/510801 · Cited by 256
Exercise as a remedy for sarcopenia
Landi, F., Marzetti, E., Martone, A. M., Bernabei, R., & Onder, G. (2013) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0000000000000018 · Cited by 255
Self-citationLegrand, D., Vaes, B., Matheï, C., Adriaensen, W., Van Pottelbergh, G., & Degryse, J. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12840 · Cited by 239
Auyeung, T. W., Lee, J. S. W., Kwok, T., & Woo, J. (2011) · The Journal of nutrition, health and aging · doi:10.1007/s12603-011-0110-9 · Cited by 248
Tanimoto, Y., Watanabe, M., Sun, W., Sugiura, Y., Tsuda, Y., Kimura, M., Hayashida, I., Kusabiraki, T., & Kono, K. (2012) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2012.06.015 · Cited by 243
“175 m/s (Cesari et al., 2009; Cruz-Jentoft et al., 2010).”
BackgroundMethodInfluentialGet a grip: individual variations in grip strength are a marker of brain health
Carson, R. G. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.07.023 · Cited by 237
Moving against frailty: does physical activity matter?
Landi, F., Abbatecola, A. M., Provinciali, M., Corsonello, A., Bustacchini, S., Manigrasso, L., Cherubini, A., Bernabei, R., & Lattanzio, F. (2010) · Biogerontology · doi:10.1007/s10522-010-9296-1 · Cited by 248
Self-citationSkeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma
Iritani, S., Imai, K., Takai, K., Hanai, T., Ideta, T., Miyazaki, T., Suetsugu, A., Shiraki, M., Shimizu, M., & Moriwaki, H. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-014-0964-9 · Cited by 246
Chou, M.-Y., Nishita, Y., Nakagawa, T., Tange, C., Tomida, M., Shimokata, H., Otsuka, R., Chen, L.-K., & Arai, H. (2019) · BMC Geriatrics · doi:10.1186/s12877-019-1199-7 · Cited by 232
Sarcopenia and Muscle Aging: A Brief Overview
Dao, T., Green, A. E., Kim, Y. A., Bae, S.-J., Ha, K.-T., Gariani, K., Lee, M.-R., Menzies, K. J., & Ryu, D. (2020) · Endocrinology and Metabolism · doi:10.3803/enm.2020.405 · Cited by 228
Earthman, C. P. (2015) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607115595227 · Cited by 234
“Subsequently, these investigators calculated SMI by dividing the skeletal muscle mass by height in meters squared and identified cutpoints to define sarcopenia based on physical disability(13); these cutpoints have been published as potential defining cutpoints (among others from the literature) in the European consen…”
MethodGschwind, Y. J., Kressig, R. W., Lacroix, A., Muehlbauer, T., Pfenninger, B., & Granacher, U. (2013) · BMC Geriatrics · doi:10.1186/1471-2318-13-105 · Cited by 221
Fukuda, Y., Yamamoto, K., Hirao, M., Nishikawa, K., Nagatsuma, Y., Nakayama, T., Tanikawa, S., Maeda, S., Uemura, M., Miyake, M., et al. (2016) · Gastric Cancer · doi:10.1007/s10120-015-0546-4 · Cited by 241
Muscle mass, BMI, and mortality among adults in the United States: A population-based cohort study
Abramowitz, M. K., Hall, C. B., Amodu, A., Sharma, D., Androga, L., & Hawkins, M. (2018) · PLOS ONE · doi:10.1371/journal.pone.0194697 · Cited by 223
Yip, C., Dinkel, C., Mahajan, A., Siddique, M., Cook, G. J. R., & Goh, V. (2015) · Insights into Imaging · doi:10.1007/s13244-015-0414-0 · Cited by 230
Liu, C., Wong, P. Y., Chung, Y. L., Chow, S. K., Cheung, W. H., Law, S. W., Chan, J. C. N., & Wong, R. M. Y. (2023) · Obesity Reviews · doi:10.1111/obr.13534 · Cited by 247
Hirani, V., Naganathan, V., Blyth, F., Le Couteur, D. G., Seibel, M. J., Waite, L. M., Handelsman, D. J., & Cumming, R. G. (2017) · Age and Ageing · doi:10.1093/ageing/afw214 · Cited by 246
Guglielmi, G., Ponti, F., Agostini, M., Amadori, M., Battista, G., & Bazzocchi, A. (2016) · Aging Clinical and Experimental Research · doi:10.1007/s40520-016-0589-3 · Cited by 221
Wang, T., Feng, X., Zhou, J., Gong, H., Xia, S., Wei, Q., Hu, X., Tao, R., Li, L., Qian, F., et al. (2016) · Scientific Reports · doi:10.1038/srep38937 · Cited by 241
Huang, D. ‐., Wang, S. ‐., Zhuang, C. ‐., Zheng, B. ‐., Lu, J. ‐., Chen, F. ‐., Zhou, C. ‐., Shen, X., & Yu, Z. (2015) · Colorectal Disease · doi:10.1111/codi.13067 · Cited by 237
Troesch, B., Eggersdorfer, M., Laviano, A., Rolland, Y., Smith, A. D., Warnke, I., Weimann, A., & Calder, P. C. (2020) · Nutrients · doi:10.3390/nu12092555 · Cited by 226
Self-citationMouse models of sarcopenia: classification and evaluation
Xie, W., He, M., Yu, D., Wu, Y., Wang, X., Lv, S., Xiao, W., & Li, Y. (2021) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12709 · Cited by 231
“In 2010, the European Working Group on Sarcopenia in Older People (EWGSOP) first proposed the widely used comprehensive diagnostic criteria for sarcopenia and recommended that muscle quality, muscle strength, and muscle function should be evaluated simultaneously in the diagnosis of sarcopenia.(2) In 2018, the EWGSOP2…”
BackgroundDiet Quality and Sarcopenia in Older Adults: A Systematic Review
Bloom, I., Shand, C., Cooper, C., Robinson, S., & Baird, J. (2018) · Nutrients · doi:10.3390/nu10030308 · Cited by 244
Rooks, D., Praestgaard, J., Hariry, S., Laurent, D., Petricoul, O., Perry, R. G., Lach‐Trifilieff, E., & Roubenoff, R. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14927 · Cited by 244
Sarcopenic obesity: time to meet the challenge
Barazzoni, R., Bischoff, S., Boirie, Y., Busetto, L., Cederholm, T., Dicker, D., Toplak, H., Van Gossum, A., Yumuk, V., & Vettor, R. (2018) · Obesity Facts · doi:10.1159/000490361 · Cited by 244
Self-citationWendrich, A. W., Swartz, J. E., Bril, S. I., Wegner, I., de Graeff, A., Smid, E. J., de Bree, R., & Pothen, A. J. (2017) · Oral Oncology · doi:10.1016/j.oraloncology.2017.05.012 · Cited by 240
Prevalence and Risk Factors of Sarcopenia in Patients With Diabetes: A Meta-analysis
Feng, L., Gao, Q., Hu, K., Wu, M., Wang, Z., Chen, F., Mei, F., Zhao, L., & Ma, B. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab884 · Cited by 243
Chentli, F., Azzoug, S., & Mahgoun, S. (2015) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.167553 · Cited by 202
Impact of quality as well as quantity of skeletal muscle on outcomes after liver transplantation
Hamaguchi, Y., Kaido, T., Okumura, S., Fujimoto, Y., Ogawa, K., Mori, A., Hammad, A., Tamai, Y., Inagaki, N., & Uemoto, S. (2014) · Liver Transplantation · doi:10.1002/lt.23970 · Cited by 242
Report from the American Society of Transplantation on frailty in solid organ transplantation
Kobashigawa, J., Dadhania, D., Bhorade, S., Adey, D., Berger, J., Bhat, G., Budev, M., Duarte-Rojo, A., Dunn, M., Hall, S., et al. (2019) · American Journal of Transplantation · doi:10.1111/ajt.15198 · Cited by 236
“Sarcopenia and frailty share similar underlying mechanisms, such as physical inactivity, chronic inflammation, and endocrine dysregulation (7,8,12).”
BackgroundBao, W., Sun, Y., Zhang, T., Zou, L., Wu, X., Wang, D., & Chen, Z. (2020) · Aging and disease · doi:10.14336/ad.2019.1012 · Cited by 186
Malafarina, V., Uriz-Otano, F., Iniesta, R., & Gil-Guerrero, L. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2012.08.001 · Cited by 231
Morley, J. E. (2012) · Family Practice · doi:10.1093/fampra/cmr063 · Cited by 218
Relationship between grip strength and global muscle strength in community-dwelling older people
Porto, J. M., Nakaishi, A. P. M., Cangussu-Oliveira, L. M., Freire Júnior, R. C., Spilla, S. B., & Abreu, D. C. C. D. (2019) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2019.03.005 · Cited by 216
Sarcopenia and menopause: The role of estradiol
Geraci, A., Calvani, R., Ferri, E., Marzetti, E., Arosio, B., & Cesari, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.682012 · Cited by 238
Mechanisms of skeletal muscle aging: insights from Drosophila and mammalian models
Demontis, F., Piccirillo, R., Goldberg, A. L., & Perrimon, N. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.012559 · Cited by 238
“The progressive loss of skeletal muscle mass and function in the aged is an important aspect of frailty that is often referred to as sarcopenia (Cruz-Jentoft et al., 2010), and it is largely responsible for the weight loss, weakness and impaired locomotion observed in the elderly.”
Interactions Between Muscle Tissues and Bone Metabolism: INTERACTIONS BETWEEN MUSCLE AND BONE
Kawao, N., & Kaji, H. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25040 · Cited by 228
Biomarkers in sarcopenia: A multifactorial approach
Curcio, F., Ferro, G., Basile, C., Liguori, I., Parrella, P., Pirozzi, F., Della-Morte, D., Gargiulo, G., Testa, G., Tocchetti, C. G., et al. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.09.007 · Cited by 225
“8 m/s and/or a grip strength b26–30 kg for men and b16–20 kg for women) (Cruz-Jentoft et al., 2010).”
Alexandre, T. D. S., Duarte, Y. A. D. O., Santos, J. L. F., Wong, R., & Lebrao, M. L. (2014) · The Journal of nutrition, health and aging · doi:10.1007/s12603-014-0540-2 · Cited by 233
“: < 30 kg for men and < 20 kg for women (3, 18, 19).”
InfluentialChilibeck, P., Kaviani, M., Candow, D., & Zello, G. A. (2017) · Open Access Journal of Sports Medicine · doi:10.2147/oajsm.s123529 · Cited by 235
Muscle loss: The new malnutrition challenge in clinical practice
Landi, F., Camprubi-Robles, M., Bear, D. E., Cederholm, T., Malafarina, V., Welch, A. A., & Cruz-Jentoft, A. J. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.11.021 · Cited by 235
Self-citationGould, H., Brennan, S. L., Kotowicz, M. A., Nicholson, G. C., & Pasco, J. A. (2014) · Calcified Tissue International · doi:10.1007/s00223-013-9830-7 · Cited by 219
da Silva Alexandre, T., de Oliveira Duarte, Y. A., Ferreira Santos, J. L., Wong, R., & Lebrão, M. L. (2014) · The Journal of nutrition, health and aging · doi:10.1007/s12603-013-0413-0 · Cited by 217
Rier, H. N., Jager, A., Sleijfer, S., Maier, A. B., & Levin, M.-D. (2016) · The Oncologist · doi:10.1634/theoncologist.2016-0066 · Cited by 226
Health Care Costs Associated With Muscle Weakness: A UK Population-Based Estimate
Pinedo-Villanueva, R., Westbury, L. D., Syddall, H. E., Sanchez-Santos, M. T., Dennison, E. M., Robinson, S. M., & Cooper, C. (2019) · Calcified Tissue International · doi:10.1007/s00223-018-0478-1 · Cited by 221
Relationship between postmenopausal osteoporosis and the components of clinical sarcopenia
Sjöblom, S., Suuronen, J., Rikkonen, T., Honkanen, R., Kröger, H., & Sirola, J. (2013) · Maturitas · doi:10.1016/j.maturitas.2013.03.016 · Cited by 222
Acute Sarcopenia Secondary to Hospitalisation - An Emerging Condition Affecting Older Adults
Welch, C., K. Hassan-Smith, Z., A. Greig, C., M. Lord, J., & A. Jackson, T. (2018) · Aging and disease · doi:10.14336/ad.2017.0315 · Cited by 223
Sarcopenia: imaging assessment and clinical application
Chianca, V., Albano, D., Messina, C., Gitto, S., Ruffo, G., Guarino, S., Del Grande, F., & Sconfienza, L. M. (2021) · Abdominal Radiology · doi:10.1007/s00261-021-03294-3 · Cited by 206
Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments
Wang, M., Tan, Y., Shi, Y., Wang, X., Liao, Z., & Wei, P. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00568 · Cited by 231
Putative Cut‐Points in Sarcopenia Components and Incident Adverse Health Outcomes: An SDOC Analysis
Cawthon, P. M., Manini, T., Patel, S. M., Newman, A., Travison, T., Kiel, D. P., Santanasto, A. J., Ensrud, K. E., Xue, Q., Shardell, M., et al. (2020) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16517 · Cited by 231
Jones, G., Trajanoska, K., Santanasto, A. J., Stringa, N., Kuo, C.-L., Atkins, J. L., Lewis, J. R., Duong, T., Hong, S., Biggs, M. L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-20918-w · Cited by 221
Huillard, O., Mir, O., Peyromaure, M., Tlemsani, C., Giroux, J., Boudou-Rouquette, P., Ropert, S., Delongchamps, N. B., Zerbib, M., & Goldwasser, F. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.58 · Cited by 227
“Recently, the condition of low muscle mass, named sarcopenia (Cruz-Jentoft et al, 2010; Fearon et al, 2011), has been studied in cancer patients, in whom sex-specific cut-off values based on mortality risks have been determined (Prado et al, 2008).”
BackgroundSex Differences in Muscle Wasting
Anderson, L. J., Liu, H., & Garcia, J. M. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-70178-3_9 · Cited by 219
Coelho-Júnior, H. J., Trichopoulou, A., & Panza, F. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101395 · Cited by 216
Buch, A., Carmeli, E., Boker, L. K., Marcus, Y., Shefer, G., Kis, O., Berner, Y., & Stern, N. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.01.008 · Cited by 227
Jung, H.-W., Kim, J. W., Kim, J.-Y., Kim, S.-W., Yang, H. K., Lee, J. W., Lee, K.-W., Kim, D.-W., Kang, S.-B., Kim, K.-I., et al. (2015) · Supportive Care in Cancer · doi:10.1007/s00520-014-2418-6 · Cited by 217
Petta, S., Ciminnisi, S., Di Marco, V., Cabibi, D., Cammà, C., Licata, A., Marchesini, G., & Craxì, A. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13889 · Cited by 215
Yoshimura, Y., Wakabayashi, H., Bise, T., Nagano, F., Shimazu, S., Shiraishi, A., Yamaga, M., & Koga, H. (2019) · Nutrition · doi:10.1016/j.nut.2018.11.005 · Cited by 219
Prevalence and overlap of sarcopenia, frailty, cachexia and malnutrition in older medical inpatients
Gingrich, A., Volkert, D., Kiesswetter, E., Thomanek, M., Bach, S., Sieber, C. C., & Zopf, Y. (2019) · BMC Geriatrics · doi:10.1186/s12877-019-1115-1 · Cited by 208
“Sarcopenia (EWGSOP [10]) Frailty (Fried et al.”
BackgroundMethodInfluentialMalnutrition, fatigue, frailty, vulnerability, sarcopenia and cachexia: overlap of clinical features
Jeejeebhoy, K. N. (2012) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328352694f · Cited by 226
Metadata
- Authors
- Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., Topinková, E., Vandewoude, M., & Zamboni, M.
- Affiliations
- Hospital Universitario Ramón y Cajal (ES)
- Damiaan Dicht bij het leven (BE)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Clermont Université 4 , UFR Médecine, UMR 1019, F-63001 Clermont-Ferrand , France
- Uppsala University (SE)
- Università Cattolica del Sacro Cuore (IT)
- Guy's and St Thomas' NHS Foundation Trust (GB)
- University Hospital of Geneva (CH)
- Hôpital de La Grave (FR)
- Centre Hospitalier Universitaire de Nice (FR)
- Charles University (CZ)
- University of Antwerp (BE)
- University of Verona (IT)
- Corresponding author
- Cruz-Jentoft, Alfonso J.
- ORCID
- Venue
- Age and Ageing
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-04-13
- Volume
- 39
- Issue
- 4
- Pages
- 412-423
- ISSN
- 0002-0729 (ISSN-L)
- 1468-2834
- PMC
- PMC2886201
- OpenAlex
- W2102902846
- Cited by
- 11,601
- References
- 80
- Citations by year
- 2026: 468 · 2025: 791 · 2024: 879 · 2023: 913 · 2022: 1031 · 2021: 1056 · 2020: 1131 · 2019: 1021 · 2018: 1059 · 2017: 811 · 2016: 685 · 2015: 591 · 2014: 494 · 2013: 290 · 2012: 207
- FWCI
- 142.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Age and Ageing (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
- reroDoc Digital Library (submittedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- European Geriatric Medicine Society
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Keywords
- sarcopenia, older adults, diagnostic criteria, muscle mass, muscle strength, physical performance, walking speed, grip strength, sarcopenic obesity, frailty, cachexia, pre-sarcopenia, cut-off values, case-finding algorithms, comprehensive geriatric assessment
- MeSH terms
- Aged, Aged, 80 and over, Aging, Cachexia, Female, Humans, Male, Obesity, Geriatric Assessment, Frail Elderly, Muscle, Skeletal, Muscle Strength, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

